Jun 19, 2020
Global Spinal Muscular Atrophy Market Outlook to 2027 - Advent of Oral mRNA Splicer for Treatment
Jun 15, 2020
June HHT Global Awareness Month Highlights COVID-19 Risk for Those With Rare Genetic Disease: As Many AS 90% Unaware They Have HHT
Jun 12, 2020
PTC Therapeutics Announces 2-year Data from Part 1 of SUNFISH and New Data from JEWELFISH Trials for Risdiplam in Patients with Spinal Muscular Atrophy
Jun 11, 2020
Verge Genomics to advance its inhibitors of PIKfyve for the treatment of ALS and COVID-19
Jun 09, 2020
The ALS Association, I AM ALS Award BrainStorm Cell Therapeutics $500,000 for ALS Biomarker Study
Jun 08, 2020
Akcea announces approval for reimbursement of TEGSEDI® (inotersen) in Italy for treatment of hereditary transthyretin amyloidosis with polyneuropathy
Jun 04, 2020
Indeed & Sports Index Team Up To Become More Inclusive In Hiring
Jun 04, 2020
Cure SMA Announces New Funding For Network Of Prominent SMA Clinical Research And Treatment Centers
Jun 04, 2020
IRLAB's Phase IIb/III Study in Parkinson's disease to Target Good ON
May 26, 2020
Impact of Baseline Dyskinesia on Safety and Efficacy of NOURIANZ® (istradefylline) in Patients with Parkinson's Disease Presented During "Virtual" European Academy of Neurology Meeting
May 26, 2020
Wicab, Inc. Granted U.S. Patent for Treatment of Impaired Motor Control or Function
May 20, 2020
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology
May 18, 2020
New Video from PANDAS Network Shows How Infections Attack Brains and Result in Devastating PANDAS/PANS Symptoms
May 14, 2020
Akcea Announces Approval for Reimbursement of TEGSEDI® (inotersen) in Spain for Treatment of Hereditary Transthyretin Amyloidosis with Polyneuropathy
May 13, 2020
Neurocrine Biosciences to Present Data from its Movement Disorder Portfolio on the American Academy of Neurology Science Highlights Platform
May 13, 2020
Answer ALS is Proud to Announce the Release of New In-Depth Biological and Clinical Datasets to Aid ALS Research
May 11, 2020
Save Nil's Life: Crowdfunding Campaign Created in Fight Against Spinal Muscular Atrophy (SMA) Type 2
Apr 30, 2020
PTC Therapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update
Apr 28, 2020
Confirmatory Part 2 of FIREFISH Demonstrates Survival and Motor Milestones Not Seen in Natural History in Infants with Type 1 Spinal Muscular Atrophy
Apr 27, 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS® (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes